Research ArticleComplications
Targeting the CDA1/CDA1BP1 Axis Retards Renal Fibrosis in Experimental Diabetic Nephropathy
Zhonglin Chai, Tieqiao Wu, Aozhi Dai, Pacific Huynh, Frank Koentgen, Guy Krippner, Shuting Ren, Mark E. Cooper
DOI: 10.2337/db18-0712 Published 1 February 2019
Zhonglin Chai
1Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia
Tieqiao Wu
1Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia
Aozhi Dai
1Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia
Pacific Huynh
1Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia
Frank Koentgen
2Ozgene Pty Ltd., Bentley, Western Australia, Australia
Guy Krippner
3Department of Commercialization, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
Shuting Ren
1Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia
4Department of Pathology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Centre, Xi’an, People’s Republic of China
Mark E. Cooper
1Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia